江苏诺泰澳赛诺生物制药股份有限公司是一家聚焦多肽药物及小分子化药，进行自主研发与定制研发相结合的生物医药企业。公司是国家高新技术企业和省级科技型企业，成立于2009年4月，位于国家级连云港经济技术开发区。公司于2021年5月20日在上海证券交易所科创板挂牌上市（股票简称：诺泰生物，代码：688076）。

Sinopep-Allsino Biopharmaceutical Co Ltd. is a premier pharmaceutical company mainly focused the research and development (R&D), production, sales and technical services of peptide and small molecule drugs. Sinopep is a National High-tech and provincial science and technology enterprise, established in April 2009, located in the Lianyungang National Economic and Technological Development Zone. On May 20th, Sinopep-Allsino was listed on the STAR Market of Shanghai Stock Exchange (Stock Name/Code: Sinopep/ 688076).